Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rosati Shannon Faith"'
Publikováno v:
Resuscitation. 85:724-731
Objective The incidence of thoracic injuries resulting from cardiopulmonary resuscitation (CPR) is not well characterized. We describe a case in which a CPR-associated atrial rupture was identified with ultrasound and successfully managed in the inte
Autor:
Rosati Shannon Faith, Paul F. Robbins, Zhili Zheng, Hui Xu, Maria R. Parkhurst, Mary A. Black, David A. Schrump, Rachel E. Beard, Young Hong, Steven A. Feldman, Daniel Abate-Daga, Richard A. Morgan, Steven A. Rosenberg, Mahadev Rao
Publikováno v:
J Immunother
Cancer testis antigens, such as NY-ESO-1, are expressed in a variety of prevalent tumors and represent potential targets for T-cell receptor (TCR) gene therapy. DNA encoding a murine anti-NY-ESO-1 TCR gene (mTCR) was isolated from immunized HLA-A*020
Autor:
Daniel Abate-Daga, John R. Wunderlich, Steven A. Rosenberg, Zhili Zheng, Richard A. Morgan, Rosati Shannon Faith, Rachel E. Beard
Purpose: The success of immunotherapy for the treatment of metastatic cancer is contingent on the identification of appropriate target antigens. Potential targets must be expressed on tumors but show restricted expression on normal tissues. To maximi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00894fb7cc80c8da3d1231277e6e7507
https://europepmc.org/articles/PMC3778100/
https://europepmc.org/articles/PMC3778100/
Autor:
Nicholas P. Schaub, James Chih-Hsin Yang, Richard M. Sherry, Udai S. Kammula, Robert Somerville, Nicholas P. Restifo, Steven A. Rosenberg, Seth M. Steinberg, Donald E. White, Debbie Ann N. Nathan, Colin A. Gross, Carolyn M. Laurencot, Giao Q. Phan, Rosati Shannon Faith, Young Hong, Michael S. Hughes, Mark E. Dudley, John R. Wunderlich
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(17)
Purpose Adoptive cell therapy (ACT) with autologous tumor-infiltrating lymphocytes (TILs) and high-dose interleukin-2 (IL-2) administered to lymphodepleted patients with melanoma can cause durable tumor regressions. The optimal TIL product for ACT is
Autor:
Zhili Zheng, Steven A. Rosenberg, Rachel E. Beard, Soldano Ferrone, Rosati Shannon Faith, Eric Tran, Daniel Abate-Daga, Stephen M. Hewitt, Kiran H. Lagisetty, William R. Burns, Richard A. Morgan, Howard A. Fine
Publikováno v:
Journal for Immunotherapy of Cancer
Background The development of immunotherapy has led to significant progress in the treatment of metastatic cancer, including the development of genetic engineering technologies that redirect lymphocytes to recognize and target a wide variety of tumor
Autor:
Rosati, Shannon Faith
Publikováno v:
Journal of Palliative Medicine; Dec2005, Vol. 8 Issue 6, p1287-1288, 2p